Prosight Management, LP

DALLAS, TX · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$515.5M2026 Q3
Positions32
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.70.6%

Prosight Management, LP reported 32 positions worth $515.5M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: LKFT (11.5%). Biggest move: reduce BSX ($31.4M).

10 / 32 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 LKFTLakefront Biotherapeutics$59.3M11.49%1,998,400——+14.6%
▸ 2 STTKShattuck Labs$52.2M10.12%7,648,094——-14.1%
▸ 3 JANXJanux Therapeutics$50.9M9.87%2,943,200——+3.2%
▸ 4 NKTRNektar Therapeutics$47.5M9.22%785,000——-38.4%
▸ 5 ABVXAbivax S.A.$37.3M7.24%376,794———
▸ 6 INSMInsmed$27.2M5.27%238,088——+6.2%
▸ 7 BSXBoston Scientific$24.0M4.66%550,000——+1.6%
▸ 8 IRTCiRhythm$22.8M4.43%200,980——-19.1%
▸ 9 ALKSAlkermes$22.3M4.32%550,000——+16.1%
▸ 10 PRVAPrivia Health$20.7M4.01%1,049,752——+24.7%

Pro Feature

The remaining 22 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Prosight Management, LP hold as of Q3 2026?

Prosight Management, LP reported 32 positions worth $515.5M in its Q3 2026 13F filing. Largest positions: LKFT (11.5%), STTK (10.1%), JANX (9.9%), NKTR (9.2%) and ABVX (7.2%).

What did Prosight Management, LP buy in Q3 2026?

New positions: PRVA, DNLI, PRAX, HQY and BBIO (9 in all). Added to: ABVX, STTK, MLYS, ALKS and IRTC (11 in all).

What did Prosight Management, LP sell in Q3 2026?

Reduced: BSX, INSM, ALNY, JANX and ADC THERAPEUTICS SA (12 in all). Sold out entirely: VEEV, CRNXGBP, ICUI, ISRG and PRCT (13 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.